Back
Sage Therapeutics Stock Price Chart
Sponsored
SAGE
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
SAGE
Sage Therapeutics
Last Price:
5.15
Seasonality Move:
13.05%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAGE is experiencing buying pressure, which is a positive indicator for future bullish movement.
Sage Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.1 | Buy |
20-day SMA: | 5.94 | Sell |
50-day SMA: | 6.71 | Sell |
200-day SMA: | 11.95 | Sell |
8-day EMA: | 5.19 | Sell |
20-day EMA: | 5.77 | Sell |
50-day EMA: | 6.69 | Sell |
200-day EMA: | 12.01 | Sell |
Sage Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.58 | Sell |
Relative Strength Index (14 RSI): | 35.68 | Sell |
Chaikin Money Flow: | 677330 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.14 - 7.48) | Sell |
Bollinger Bands (100): | (6.13 - 10.09) | Sell |
Sage Therapeutics Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Sage Therapeutics Stock
Is Sage Therapeutics Stock a Buy?
- Sage Therapeutics share price is 5.17 while SAGE 8-day simple moving average is 5.10, which is a Buy signal.
- The stock price of SAGE is 5.17 while Sage Therapeutics 20-day SMA is 5.94, which makes it a Sell.
- Sage Therapeutics 50-day simple moving average is 6.71 while SAGE share price is 5.17, making it a Sell technically.
- SAGE stock price is 5.17 and Sage Therapeutics 200-day simple moving average is 11.95, creating a Sell signal.
SAGE Technical Analysis vs Fundamental Analysis
Sell
27
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics a Buy or a Sell?
-
Sage Therapeutics stock is rated a Sell
The current Sage Therapeutics [SAGE] share price is $5.17. The Score for SAGE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Sage Therapeutics Stock Info
Market Cap:
316.27M
Price in USD:
5.17
Share Volume:
870.85K
Sage Therapeutics 52-Week Range
52-Week High:
28.26
52-Week Low:
4.62
Sell
27
Sage Therapeutics (SAGE)
is a Sell
Sage Therapeutics Share Price Forecast
-
What is the Sage Therapeutics stock price today?
The Sage Therapeutics stock price is 5.17 USD today. -
Will SAGE stock go up or go down?
Sage Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Sage Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sage Therapeutics is overvalued.
Is Sage Therapeutics Stock a Buy?
- Sage Therapeutics share price is 5.17 while SAGE 8-day exponential moving average is 5.19, which is a Sell signal.
- The stock price of SAGE is 5.17 while Sage Therapeutics 20-day EMA is 5.77, which makes it a Sell.
- Sage Therapeutics 50-day exponential moving average is 6.69 while SAGE share price is 5.17, making it a Sell technically.
- SAGE stock price is 5.17 and Sage Therapeutics 200-day simple moving average is 12.01, creating a Sell signal.
Fundamental Analysis of Sage Therapeutics
Is Sage Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.06 per share, and an increase next year of $2.71 per share.
Technical Analysis of Sage Therapeutics
Should I short Sage Therapeutics stock?
- SAGE Moving Average Covergence Divergence (MACD) indicator is -0.58, suggesting Sage Therapeutics is a Sell
- Sage Therapeutics Relative Strength Index (RSI) is 35.68, which suggest Sage Therapeutics is oversold
- The Bollinger Bands (25) for Sage Therapeutics is (5.14 - 7.48), which suggest Sage Therapeutics is a Sell
- The Bollinger Bands (100) for Sage Therapeutics is (6.13 - 10.09), which suggest Sage Therapeutics is a Sell
* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.